Home > News > Editor Favorites

Principi prodded VA on Chantix

Ex-secretary asked if use would continue

By Audrey Hudson and Jen Haberkorn | Wednesday, July 9, 2008

Article
Comments ()

EXCLUSIVE: Former Veterans Affairs Secretary Anthony J. Principi contacted colleagues at his old agency as the chief lobbyist for drug maker Pfizer Inc. earlier this year, looking for updates on whether his company's smoking-cessation drug Chantix would remain on the VA's list of approved prescription drugs amid new warnings of dangerous side effects.

The government had just banned Chantix for use by pilots and air traffic controllers because of potential side effects on alertness and motor skills and had more broadly warned that the medicine could cause depression, suicidal thoughts and attempted suicide. Pfizer wanted insight on the VA's intent for the drug, which has been prescribed to thousands of veterans.

Pfizer officials maintain that Mr. Principi's contacts at his old agency did not amount to lobbying and that all he did was pass along requests via e-mail asking whether an internal study that examined 27 veterans hospitalized for psychotic episodes while taking Chantix would be made public.

E-mails reviewed by The Washington Times also reveal that Mr. Principi forwarded inquiries from Pfizer about Chantix's status on the VA's list of prescribed drugs, at one point stating, "I really hate to be a pain, but I keep getting asked these questions."

Mr. Principi's private work after serving as President Bush's first VA secretary from 2001 though early 2005 provides what ethics analysts say is a textbook case of the "revolving door," in which former Cabinet secretaries, powerful lawmakers and well-connected regulators land lucrative jobs helping corporate America influence federal policy and decisions by their former colleagues. The practice is legal, but frequently raises concerns about the appearance of conflicts of interest.

The Clinton administration addressed the issue with a sweeping order that banned top officials from lobbying the government until five years after they left public service for the private sector.

But President Clinton ended that five-year ban just before he left office, in January 2001. The Bush administration then reverted to the one-year ban that was enacted as part of the Ethics Reform Act of 1989. Congress in 2007 increased the waiting period to two years, but by that time it did not apply to Mr. Principi.

Mr. Principi declined to be quoted for this story, including answering whether he began interviewing for the Pfizer job while he was still VA secretary in 2004.

But his company's dealings with the VA have taken on new importance as Congress investigates why the veterans agency took months to alert its patients about Chantix's new side effects, such as suicide and psychosis, even when it knew veterans suffering from post-traumatic stress disorder (PTSD) were among those taking the drug.

The first hearings, prompted by a series of stories in The Times over the past month, is set to open today before the House Veterans' Affairs Committee.